Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5B which would create the third-biggest specialty pharmaceutical company in the U.S

READ ALL THIS AT
http://www.pharmpro.com/news/2013/05/actavis-buying-warner-chilcott-85b-deal?et_cid=3264804&et_rid=519587661&linkid=http%3a%2f%2fwww.pharmpro.com%2fnews%2f2013%2f05%2factavis-buying-warner-chilcott-85b-deal
Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5B which would create the third-biggest specialty pharmaceutical company in the U.S